2632292
Last Update Posted: 2019-09-26
Recruiting has ended
All Genders accepted | 18 Years + |
33 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus
Prospective, randomized, controlled, multicenter, open-label study to compare everolimus-eluting bioresorbable vascular scaffolds to everolimus-eluting stents in patients with diabetes mellitus.
Eligibility
Relevant conditions:
Coronary Artery Disease
Diabetes Mellitus
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov